Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BE-PEOPLE P3: Bedaquiline Enhanced Post Exposure Prophylaxis for Leprosy
NCT05597280Phase 3Recruiting
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Mar 2023
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bedaquiline in leprosy (HD), sponsored by Institute of Tropical Medicine Antwerp. Started Mar 2023; status: recruiting.
02
Drugs
bedaquiline
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on NCT05597280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05597280.